Medscape

FDA Okays AI-Based Prostate Cancer Risk-Stratification Tool

The US FDA has granted De Novo marketing authorization for ArteraAI Prostate (Artera, Los Altos, California), a novel artificial intelligence (AI)-powered risk-stratification tool for patients with ...
Medical Xpress

Easy-to-use tool can identify high- and low-risk metastatic prostate cancer patients earlier

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment intensification can meaningfully improve survival for patients with ...
KSL

U. researchers unveil AI-powered tool for disease prediction with 'unprecedented accuracy'

SALT LAKE CITY — It's long been a goal in medicine to better understand the long trajectories of diseases in hopes of engaging in better prevention and early intervention. "Collectively, they're ...
ascopubs.org

Artificial Intelligence–Based Digital Histologic Classifier for Prostate Cancer Risk Stratification: Independent Blinded Validation in Patients Treated With Radical Prostatectomy

Artificial intelligence (AI) tools that identify pathologic features from digitized whole-slide images (WSIs) of prostate cancer (CaP) generate data to predict outcomes. The objective of this study ...
ascopubs.org

Patient-generated health DATA as a risk stratification tool: Real-world multidisciplinary care study from a developing-country private clinic.

Racial differences in prevalence of coronary artery calcification among patients undergoing lung cancer screening. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...